Nebojša Lalić

10.8k citations

137 papers · 4.0k indexed · 2 hit papers · h-index 29

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Management and Research 41
- Diabetes Treatment and Management 34
- Diabetes, Cardiovascular Risks, and Lipoproteins 15
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 8
Endocrine and Autonomic Systems top 5%
Physiology top 5%
Obstetrics and Gynecology top 5%
Surgery top 5%
- Pancreatic function and diabetes 27
Genetics
- Diabetes and associated disorders 27
Molecular Biology
- Metabolism, Diabetes, and Cancer 20
Cardiology and Cardiovascular Medicine
- Cardiovascular Function and Risk Factors 11

Co-authors: Andrea Natali Ele Ferrannini Geltrude Mingrone P. Cavallo‐Perin P. M. Bell Katarina Lalić Aleksandra Jotić Rafael Simó
Cited by: Endocrinology, Diabetes and Metabolism Endocrine and Autonomic Systems Physiology
Partner nations: Serbia Italy Czechia

In The Last Decade

Nebojša Lalić

131 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2009 Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
1997 Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

Peers

Countries citing papers authored by Nebojša Lalić

Since Specialization

Citations

This map shows the geographic impact of Nebojša Lalić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nebojša Lalić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nebojša Lalić more than expected).

Fields of papers citing papers by Nebojša Lalić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nebojša Lalić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nebojša Lalić. The network helps show where Nebojša Lalić may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nebojša Lalić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nebojša Lalić Line = papers co-authored together Nebojša Lalić links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetes Tadej Battelino,Nebojša Lalić,Sufyan Hussain,Antonio Ceriello,Sanja Klobučar Majanović,Sarah Davies,Pınar Topsever,Julie Heverly,Francesca Ulivi,Kevin Brady,Tsvetalina Tankova,Júlia Galhardo,Kostas Tagkalos,Erik Werson,Chantal Mathieu,Peter Schwarz	2025	3
2	Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms Martina Chiriacò,Domenico Tricò,John R. Petrie,Rafael Gabriel,Amalia Gastaldelli,John J. Nolan,Nebojša Lalić,Geltrude Mingrone,Andrea Mari,Andrea Natali	2025	0
3	Insulin Secretion and Insulin Sensitivity Change in Different Stages of Adult-Onset Type 1 Diabetes: A Cross-Sectional Study Tanja Miličić,Aleksandra Jotić,Katarina Lalić,Ljiljana Lukić,Marija Maćešić,Jelena Stanarčić Gajović,Milica Stoiljković,Mina M. Milovancevic,Djurdja P. Rafailovic,Aleksandra Bozovic,Nebojša Lalić	2025	1
4	Assessment of cardiovascular risk in patients with type 2 diabetes and albuminuric diabetic kidney disease phenotype Milica Vujasevic,Nebojša Lalić,Aleksandra Jotić,Tanja Miličić,Marija Maćešić,Ljiljana Lukić	2024	0
5	Unveiling the Spectrum of Glucose Variability: A Novel Perspective on FreeStyle Libre Monitoring Data Adrian Heald,Mike Stedman,John Warner‐Levy,Lleyton Belston,Angela Paisley,Aleksandra Jotić,Nebojša Lalić,Martin Gibson,Hellena Habte-Asres,Martin Whyte,Angus Forbes	2024	1
6	Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group Andrej Janež,Emir Muzurović,Paweł Bogdański,Leszek Czupryniak,Ľubomíra Fábryová,Zlatko Fras,Cristian Guja,Martin Haluzı́k,Péter Kempler,Nebojša Lalić,Dana Müllerová,Anca Pantea Stoian,Νικόλαος Παπάνας,Dario Rahelić,José Silva‐Nunes,Tsvetalina Tankova,Volkan Yumuk,Manfredi Rizzo	2024	12
7	Glucose lowering drug or strategy dependent impact of weight reduction on the prevention of CVD outcomes in Type 2 diabetes: a systematic review of CVOTs Nebojša Lalić,Aleksandra Jotić,Ljiljana Lukić,Tanja Miličić,Marija Maćešić,Jelena Stanarčić Gajović,Milica Stoiljković,Mina M. Milovancevic,D. Cvetkovic,Katarina Lalić	2024	1
8	NT-proBNP point-of-care measurement as a screening tool for heart failure and CVD risk in type 2 diabetes with hypertension Antonio Ceriello,Nebojša Lalić,Eduard Montanya,P. Valensi,Kamlesh Khunti,Michael Hummel,Oliver Schnell	2023	9
9	Prof. dr Đorđe Joannović, a corresponding member of Serbian Royal Academy, Dean, pathologist and the first Serbian oncologist, one of the world pioneers of the study of autoaggression, the founder and builder of the Institute of Pathology, the most tragic personality in the one-century-long history of the Faculty of Medicine: 151 years since birth and 90 years since death Vladimir Kanjuh,Sanja Radojević-Škodrić,Lazar Davidović,Nebojša Lalić	2023	0
10	Matrix metalloproteinase-2 (MMP-2 ) and-9 (MMP-9) gene variants and microvascular complications in type 2 diabetes patients Jelic M Andjelic,D. Radojković,Aleksandra Nikolić,Ljiljana Rakićević,Tamara Babič,D Jelic,Nebojša Lalić	2022	2
11	Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe Andrej Janež,Tadej Battelino,Tomasz Klupa,Győző Kocsis,M Kuricova,Nebojša Lalić,Anca Pantea Stoian,Martin Prázný,Dario Rahelić,Jan Šoupal,Tsvetalina Tankova,Nataliya Zelinska	2021	23
12	Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era Antonio Ceriello,Eberhard Standl,Doina Catrinoiu,Baruch Itzhak,Nebojša Lalić,Dario Rahelić,Oliver Schnell,J Skrha,Paul Valensi	2020	57
13	Risk factors clustering within the metabolic syndrome: a pattern or by chance? Biljana Parapid,Miodrag Ostojić,Nebojša Lalić,Dragan Micić,Svetozar Damjanović,Dragana Bubanja,Dragan Šimić,Katarina Lalić,Snežana Polovina,Jelena Marinković,Nataša Milić	2015	6
14	Decreased Insulin Sensitivity and Impaired Fibrinolytic Activity in Type 2 Diabetes Patients and Nondiabetics with Ischemic Stroke Aleksandra Jotić,Tanja Miličić,Nadezda Covickovic Sternic,Vladimir Kostić,Katarina Lalić,Veljko Jeremić,Milija Mijajlović,Ljiljana Lukić,N. Rajković,Milorad Čivčić,Marija Maćešić,Jelena P. Seferović,J. Stanarcic,Sandra Aleksić,Nebojša Lalić	2015	10
15	High Risk First Degree Relatives of Type 1 Diabetics: An Association with Increases in CXCR3⁺T Memory Cells Reflecting an Enhanced Activity of Th1 Autoimmune Response Tanja Miličić,Aleksandra Jotić,Ivanka Marković,Katarina Lalić,Veljko Jeremić,Ljiljana Lukić,N. Rajković,Dušan Popadić,Marija Maćešić,Jelena P. Seferović,Sandra Aleksić,J. Stanarcic,Milorad Čivčić,Nebojša Lalić	2014	2
16	The role of glycemia in acute heart failure patients Jelena P. Seferović,Ivan Milinković,Milorad Tešić,Arsen Ristić,Nebojša Lalić,Dejan Simeunović,Ivana Živković,Salvatore Di Somma,Petar Seferović	2014	7
17	Self-Monitoring of Blood Glucose in Diabetes: From Evidence to Clinical Reality in Central and Eastern Europe—Recommendations from the International Central-Eastern European Expert Group Leszek Czupryniak,László Barkai,Svetlana Bolgarska,Agata Bronisz,Jan Brož,Katarzyna Cypryk,Marek Honka,Andrej Janež,Mladen Krnić,Nebojša Lalić,Emil Martinka,Dario Rahelić,Gabriela Román,Tsvetalina Tankova,Tamás Várkonyi,Bogumił Wolnik,Nadiia Zherdova	2014	60
18	Type 2 Diabetic Patients with Ischemic Stroke: Decreased Insulin Sensitivity and Decreases in Antioxidant Enzyme Activity Are Related to Different Stroke Subtypes Aleksandra Jotić,Nadezda Covickovic Sternic,Vladimir Kostić,Katarina Lalić,Tanja Miličić,Milija Mijajlović,Ljiljana Lukić,Milorad Čivčić,Emina Čolak,Marija Maćešić,Jelena P. Seferović,Sandra Aleksić,Nebojša Lalić	2013	7
19	3rd Annual Symposium on Self Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 7–8, 2010, London, UK Nebojša Lalić,B. Landers	2010	2
20	Low and high density lipoprotein--cholesterol and coronary atherothrombosis. Vladimir Kanjuh,Miodrag Ostojić,Nebojša Lalić,Edita Stokić,Nada Adić-Cemerlić,Ljiljana Gojković‐Bukarica	2009	3

About Nebojša Lalić

Nebojša Lalić is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery, having authored 137 papers that have together received 4.0k indexed citations. Recurring topics across this work include Diabetes Management and Research (41 papers), Diabetes Treatment and Management (34 papers), Diabetes and associated disorders (27 papers), Pancreatic function and diabetes (27 papers), Metabolism, Diabetes, and Cancer (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Cardiovascular Function and Risk Factors (11 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.3k citations), Endocrine and Autonomic Systems (187 citations) and Physiology (690 citations). Nebojša Lalić has collaborated with scholars based in Serbia, Italy and Czechia. Frequent co-authors include Andrea Natali, Ele Ferrannini, Geltrude Mingrone, P. Cavallo‐Perin, P. M. Bell, Katarina Lalić, Aleksandra Jotić, Rafael Simó, Slobodan Antić and Allan Vaag.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact